Ben Synth examines how BPC-157 evolved from obscure Croatian research into a multimillion-dollar phenomenon. We trace the compound's journey through bodybuilding forums, Joe Rogan's podcast, wellness influencers, and unregulated supply chains—exploring the gap between rodent data and human evidence, while discussing why desperate patients turn to experimental peptides despite FDA warnings and zero large-scale clinical trials.
Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV
This content was created in partnership and with the help of Artificial Intelligence AI
続きを読む
一部表示